Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Becton Dickinson and Company (BDX)
Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 67,707,792
  • Shares Outstanding, K 283,902
  • Annual Sales, $ 18,870 M
  • Annual Income, $ 1,779 M
  • 60-Month Beta 0.53
  • Price/Sales 3.54
  • Price/Cash Flow 12.04
  • Price/Book 2.63
Trade BDX with:

Options Overview Details

View History
  • Implied Volatility 19.80% ( +0.06%)
  • Historical Volatility 16.00%
  • IV Percentile 8%
  • IV Rank 9.56%
  • IV High 35.45% on 10/10/22
  • IV Low 18.14% on 02/03/23
  • Put/Call Vol Ratio 8.23
  • Today's Volume 1,366
  • Volume Avg (30-Day) 511
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 25,936
  • Open Int (30-Day) 33,873

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate 2.76
  • Number of Estimates 10
  • High Estimate 2.86
  • Low Estimate 2.73
  • Prior Year 3.18
  • Growth Rate Est. (year over year) -13.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
228.62 +4.42%
on 03/13/23
241.96 -1.34%
on 02/22/23
-0.79 (-0.33%)
since 02/21/23
3-Month
228.62 +4.42%
on 03/13/23
262.66 -9.12%
on 01/03/23
-14.65 (-5.78%)
since 12/21/22
52-Week
215.90 +10.57%
on 10/13/22
277.29 -13.91%
on 04/08/22
-28.89 (-10.80%)
since 03/21/22

Most Recent Stories

More News
Catalent (CTLT) Inks Deal for New & Effective Drug Delivery

Catalent (CTLT) will use Bhami Research Laboratory's technology to evaluate and develop drug-delivery system for high-concentration therapies, thereby increasing effectiveness.

BDX : 239.18 (+0.29%)
HSIC : 79.64 (+1.04%)
COO : 347.94 (+1.00%)
CTLT : 66.96 (-0.03%)
BD's (BDX) New FDA Approval to Improve Vaginitis Testing

BD's (BDX) receipt of the latest FDA approval is likely to improve the detection and prevention of vaginitis.

BDX : 239.18 (+0.29%)
HOLX : 79.10 (+1.01%)
HSIC : 79.64 (+1.04%)
AVNS : 29.31 (+2.70%)
Reasons to Retain Cardinal Health (CAH) in Your Portfolio

Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.

BDX : 239.18 (+0.29%)
CAH : 71.64 (+0.70%)
HSIC : 79.64 (+1.04%)
COO : 347.94 (+1.00%)
BD Receives FDA 510(k) Clearance for First-of-Its-Kind High-Throughput Diagnostic Test for Infectious Vaginitis

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k)...

BDX : 239.18 (+0.29%)
PacBio's (PACB) Latest Offering to Enhance Genome Analysis

PacBio's (PACB) new informatics analysis method, Paraphase, will enable researchers to genotype gene paralogs and pseudogenes with high accuracy.

BDX : 239.18 (+0.29%)
HSIC : 79.64 (+1.04%)
COO : 347.94 (+1.00%)
PACB : 9.12 (+9.09%)
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a concern.

BDX : 239.18 (+0.29%)
ABC : 155.74 (+1.22%)
HSIC : 79.64 (+1.04%)
COO : 347.94 (+1.00%)
Healthcare Stocks With at Least 30 Years of Dividend Increases

Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.

ABT : 97.76 (-0.11%)
ABBV : 155.82 (-0.19%)
BDX : 239.18 (+0.29%)
CAH : 71.64 (+0.70%)
JNJ : 152.62 (-0.83%)
MDT : 80.71 (+1.38%)
ROP : 426.06 (-1.42%)
WST : 335.51 (+1.07%)
PerkinElmer (PKI) Completes Divestment, New Business Name in Q2

PerkinElmer (PKI) completes separation of its businesses into two entities ??? the AES business, and the Life Sciences and Diagnostics business.

BDX : 239.18 (+0.29%)
HSIC : 79.64 (+1.04%)
PKI : 125.23 (+1.18%)
COO : 347.94 (+1.00%)
3 Stocks to Buy for Consistent Dividend Growth

Some of these companies have been around for over 100 years and have seen all imaginable economic environments

BDX : 239.18 (+0.29%)
HSY : 242.80 (-0.71%)
AFL : 64.70 (+2.08%)
Three Reasons to Add BD (BDX) Stock to Your Portfolio Now

Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and product launches.

BDX : 239.18 (+0.29%)
MCK : 346.24 (+0.29%)
HOLX : 79.10 (+1.01%)
AVNS : 29.31 (+2.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 243.66
2nd Resistance Point 241.55
1st Resistance Point 240.02
Last Price 239.18
1st Support Level 236.37
2nd Support Level 234.26
3rd Support Level 232.73

See More

52-Week High 277.29
Fibonacci 61.8% 253.84
Fibonacci 50% 246.60
Fibonacci 38.2% 239.35
Last Price 239.18
52-Week Low 215.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar